title: Modulatory effect of a serine protease inhibitor on surgical stress: its clinical implications.
abstract: The relationship between endogenous cytokine antagonists and surgical stress is poorly understood. Surgical stress induces immunosuppression, and the reversed therapy of postoperative immunosuppression has been expected. The aim of the present study was to assess the effect of a serine protease inhibitor on postoperative immune reactivity. Twenty patients with colorectal cancer were randomly separated into experimental and control groups of 10 patients each. The experimental group received perioperative administration of a serine protease inhibitor while the control group did not. Plasma levels of cytokine antagonists, which suppress cell-mediated immunity, such as cortisol, interleukin-1 receptor antagonist, soluble interleukin-2 receptor (sIL-2R) and soluble tumor necrosis factors p55, p75 (sTNF-R55, -R75) were simultaneously measured. Significant reductions of plasma concentration of sIL-2R and sTNF-R55 were observed. Perioperative administration of a serine protease inhibitor may contribute to ameliorating immunosuppression after major surgery.
authors.affiliation: First Department of Surgery, Okayama University Medical School, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Iwagaki
authors.forename: T
authors.initials: T
authors.lastname: Yagi
authors.forename: N
authors.initials: N
authors.lastname: Urushihara
authors.forename: K
authors.initials: K
authors.lastname: Kobashi
authors.forename: Y
authors.initials: Y
authors.lastname: Morimoto
authors.forename: H
authors.initials: H
authors.lastname: Isozaki
authors.forename: N
authors.initials: N
authors.lastname: Takakura
authors.forename: N
authors.initials: N
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000368:Aged; D001550:Benzamidines; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D015375:Receptors, Interleukin-2 / Q000097:blood; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*; D012995:Solubility; D013312:Stress, Physiological / Q000097:blood / Q000276:immunology*
chemical_list: D001550:Benzamidines; D006146:Guanidines; D015375:Receptors, Interleukin-2; D018124:Receptors, Tumor Necrosis Factor; D015842:Serine Proteinase Inhibitors; C032855:nafamostat